Author:
Malentacchi Francesca,Pizzamiglio Sara,Verderio Paolo,Pazzagli Mario,Orlando Claudio,Ciniselli Chiara Maura,Günther Kalle,Gelmini Stefania
Abstract
AbstractCirculating cell-free DNA (ccfDNA) has been confirmed as a useful biomarker in cancer and pre-natal clinical practice. One of the main critical points in using ccfDNA is a lack of standardisation for sample processing methods, storage conditions, procedures for extraction, and quantification that can affect ccfDNA quality and quantity. We report the results obtained from the SPIDIA-DNAplas, one of the EU SPIDIA (Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics) subprojects based on the implementation of an External Quality Assessment scheme for the evaluation of the influence of the pre-analytical phase on ccfDNA. This is the first reported quality control scheme targeting ccfDNA for pre-analytical phase studies.Fifty-six laboratories throughout Europe were recruited. The participating laboratories received the same plasma sample and extracted ccfDNA by using their own procedures, at defined plasma storage conditions, and sent the isolated ccfDNA to the SPIDIA facility for analyses. Laboratory performance was evaluated by using specific quality parameters such as ccfDNA integrity (by multiplex PCR) and yield (by qPCR).The analysis of the ccfDNA extracted by the laboratories showed that most of them (53 of 56) were able to recover ccfDNA but only 12.5% recovered non-fragmented ccfDNA. Extraction methods specifically designed for ccfDNA preserved the integrity profile.The evidence-based results of the SPIDIA-DNAplas EQA have been proposed as a basis for the development of a Technical Specification by the European Committee for standardisation (CEN).
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference58 articles.
1. Circulating nucleic acids as a tumor marker;Chan;Histol Histopathol,2002
2. - free DNA in the blood as a solid tumor biomarker a critical appraisal of the literature;Jung;Cell Clin Chim Acta,2010
3. Free circulating DNA as possible tumor marker in colorectal cancer;Boni;Surg Oncol,2007
4. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients;Frattini;J Clin Oncol,2005
5. Del High fragmentation characterized tumour - derived circulating DNA;Muoliere,2011
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献